Report cover image

Europe Point-of-Care (POC) Drug Abuse Testing Market

Publisher Data Bridge Market Research
Published Sep 01, 2024
Length 476 Pages
SKU # DAABD19472219

Description

Europe Point-of-Care (POC) Drug Abuse Testing Market


Europe Point-of-Care (POC) drug abuse testing market is expected to reach USD 543.00 million by 2031 from USD 392.45 million in 2023, growing at a CAGR of 4.3% in the forecast period of 2024 to 2031.


Europe Point-of-Care (POC) Drug Abuse Testing Market, By Drug Type (Amphetamines, Opiates, Cannabinoids, Cocaine, Barbiturates, Benzodiazepines, Methadone, Phencyclidine, Tricyclic Antidepressants, and Others), Products (Devices and Consumables and Accessories), Prescription (Over the Counter Testing and Prescription-Based Testing), Sample Type (Urine, Saliva, Blood, Hair, Breath, and Others), Testing Type (Random Testing, Post-Incident Testing, and Abstinence Testing), Application (Medical Screening, Workplace Screening, Law Enforcement and Criminal Justice, Pain Management, Substance Abuse Treatment and Rehabilitation, Parental or Home Drug Testing, Sports and Athletics Testing, Drug Screening in Schools and Educational Institutions, and Others), End User (Healthcare Facilities, Employers, Government Institutes, and Others), Distribution Channel (Direct Tender, Retails Sales, and Others), Countries (Germany, France, U.K., Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Belgium, Norway, Austria, Hungary, Ireland, Kazakhstan, Belarus, Lithuania, Uzbekistan, Azerbaijan, Armenia, Moldova, Tajikistan, Kyrgyzstan, Poland, Rest of Europe) - Industry Trends and Forecast to 2031
Overview of Europe Point-of-Care (POC) Drug Abuse Testing Market Dynamics:

Driver

• Rising incidence of drug abuse
Restrain

• Data security and privacy concerns

Opportunity

• Growing awareness and the campaign for drug testing
Market Players:

The key market players operating in the Europe Point-of-Care (POC) drug abuse testing market are listed below:

• Abbott
• Agilent Technologies
• BD
• Bio-rad Laboratories inc.
• F.HOFFMAN-LA ROCHE LTD.
• MERCK KGAA, DARMSTADT, GERMANY
• BASF SE
• Quest Diagnostics
• SIEMENS HEALTHINEERS AG
• THERMO FISHER SCIENTIFIC INC.
• WONDFO

Table of Contents

476 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The Europe Point-of-care (Poc) Drug Abuse Testing Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modelling
2.7 Market Application Coverage Grid
2.8 Product Lifeline Curve
2.9 Dbmr Market Position Grid
2.10 Vendor Share Analysis
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestal Analysis
4.2 Porters Five Forces Analysis
5 Market Overview
5.1 Drivers
5.1.1 Rising Incidence Of Drug Abuse
5.1.2 Growing Emphasis On Workplace Safety
5.1.3 Growth In Home And Parental Drug Testing Kits
5.1.4 Rising Use Of Poc Testing In Healthcare Facilities
5.2 Restraints
5.2.1 Data Security And Privacy Concerns
5.2.2 Lack Of Accuracy And Technical Challenges
5.3 Opportunities
5.3.1 Growing Awareness And The Campaign For Drug Testing
5.3.2 Strategic Initiation And Decision Taken By The Market Players
5.3.3 Expanding Product Range For Point-of-care Drug Abuse Testing
5.4 Challenges
5.4.1 Limited Awareness And Acceptance
5.4.2 High Costs Associated With The Testing
6 Europe Point-of-care (Poc) Drug Abuse Testing Market, By Drug Type
6.1 Overview
6.2 Amphetamines
6.3 Opiates
6.4 Cannabinoids
6.5 Cocaine
6.6 Barbiturates
6.7 Benzodiazepines
6.8 Methadone
6.9 Phencyclidine
6.10 Tricyclic Antidepressants
6.11 Others
7 Europe Point-of-care (Poc) Drug Abuse Testing Market, By Products
7.1 Overview
7.2 Devices
7.2.1 Analyzer
7.2.1.1 Immunoassay Analyzer
7.2.1.1.1 High Volume
7.2.1.1.2 Mid Volume
7.2.1.1.3 Low Volume
7.2.1.2 Breathalyzer
7.2.1.2.1 Electrochemical Fuel Cell Breath Analyzers
7.2.1.2.2 Infrared Optical Sensor Breath Analyzers
7.2.1.2.3 Semiconductor Breath Analyzers
7.2.2 Rapid Devices
7.2.3 Drug Testing Cassette
7.2.4 Drug Testing Cups
7.2.5 Dip Cards/Strips
7.2.6 Oral Fluid Testing Devices
7.2.7 Others
7.2.8 Modality
7.2.9 Handheld
7.2.10 Mobile
7.2.11 Manual
7.2.12 Automated
7.3 Consumables And Accessories
7.3.1 Assay Kits And Reagents
7.3.2 Probes
7.3.3 Others
7.3.3.1 Dast-10
7.3.3.2 Plasma Protein Binding
7.3.3.3 Plasma And Serum Stability
7.3.3.4 Others
7.3.3.4.1 Multi-panel Drug Test Kits
7.3.3.4.2 Single-panel Drug Test Kits
8 Europe Point-of-care (Poc) Drug Abuse Testing Market, By Prescription
8.1 Overview
8.2 Over The Counter Testing
8.3 Prescription-based Testing
9 Europe Point-of-care (Poc) Drug Abuse Testing Market, By Sample Type
9.1 Overview
9.2 Urine
9.3 Saliva
9.4 Blood
9.5 Hair
9.6 Breath
9.7 Others
10 Europe Point-of-care (Poc) Drug Abuse Testing Market, By Testing Type
10.1 Overview
10.2 Random Testing
10.3 Post-incident Testing
10.4 Abstinence Testing
11 Europe Point-of-care (Poc) Drug Abuse Testing Market, By Application
11.1 Overview
11.2 Medical Screening
11.3 Workplace Screening
11.4 Law Enforcement And Criminal Justice
11.5 Pain Management
11.6 Substance Abuse Treatment And Rehabilitation
11.7 Parental Or Home Drug Testing
11.8 Sports And Athletics Testing
11.9 Drug Screening In Schools And Educational Institutions
11.10 Others
12 Europe Point-of-care (Poc) Drug Abuse Testing Market, By End User
12.1 Overview
12.2 Healthcare Facilities
12.2.1 Hospitals
12.2.2 Emergency Department
12.2.3 Central Labs
12.2.4 Clinics
12.2.5 Poison Control Centers
12.2.6 Others
12.3 Employers
12.4 Government Institutes
12.5 Others
13 Europe Point-of-care (Poc) Drug Abuse Testing Market, By Distribution Channel
13.1 Overview
13.2 Direct Tender
13.3 Retail Sales
13.4 Others
14 Europe Point-of-care (Poc) Drug Abuse Testing Market, By Region
14.1 Europe
14.1.1 Germany
14.1.2 U.K.
14.1.3 France
14.1.4 Italy
14.1.5 Spain
14.1.6 Turkey
14.1.7 Russia
14.1.8 Switzerland
14.1.9 Netherlands
14.1.10 Belgium
14.1.11 Austria
14.1.12 Norway
14.1.13 Poland
14.1.14 Hungary
14.1.15 Ireland
14.1.16 Kazakhstan
14.1.17 Belarus
14.1.18 Lithuania
14.1.19 Uzbekistan
14.1.20 Azerbaijan
14.1.21 Armenia
14.1.22 Moldova
14.1.23 Tajikistan
14.1.24 Kyrgyzstan
14.1.25 Rest Of Europe
15 Europe Point-of-care (Poc) Drug Abuse Testing Market: Company Landscape
15.1 Company Share Analysis: Europe
16 Swot Analysis
17 Company Profiles
17.1 Abbott Laboratories
17.1.1 Company Snapshot
17.1.2 Revenue Analysis
17.1.3 Company Share Analysis
17.1.4 Product Portfolio
17.1.5 Recent Development
17.2 Siemens Healthineers Ag
17.2.1 Company Snapshot
17.2.2 Revenue Analysis
17.2.3 Company Share Analysis
17.2.4 Product Portfolio
17.2.5 Recent Developments
17.3 Quest Diagnostics Incorporated
17.3.1 Company Snapshot
17.3.2 Revenue Analysis
17.3.3 Company Share Analysis
17.3.4 Product Portfolio
17.3.5 Recent Development
17.4 Thermo Fisher Scientific Inc.
17.4.1 Company Snapshot
17.4.2 Revenue Analysis
17.4.3 Company Share Analysis
17.4.4 Product Portfolio
17.4.5 Recent Development
17.5 F.Hoffman-la Roche Ltd.
17.5.1 Company Snapshot
17.5.2 Revenue Analysis
17.5.3 Company Share Analysis
17.5.4 Product Portfolio
17.5.5 Recent Updates
17.5.6 Recent Updates
17.6 Accubiotech Co., Ltd.
17.6.1 Company Snapshot
17.6.2 Product Portfolio
17.6.3 Recent Development
17.7 Advacare Pharma
17.7.1 Company Snapshot
17.7.2 Product Portfolio
17.7.3 Recent Updates
17.8 Agilent Technologies, Inc
17.8.1 Company Snapshot
17.8.2 Revenue Analysis
17.8.3 Product Portfolio
17.8.4 Recent Updates
17.9 Assure Tech (Hangzhou) Co., Ltd.
17.9.1 Company Snapshot
17.9.2 Product Portfolio
17.9.3 Recent Development
17.10 Bd
17.10.1 Company Snapshot
17.10.2 Revenue Analysis
17.10.3 Product Portfolio
17.10.4 Recent Development
17.11 Beijing Hotgen Biotechn Co., Ltd.
17.11.1 Company Snapshot
17.11.2 Product Portfolio
17.11.3 Recent Development
17.12 Bioeasy Biotechnology Co., Ltd.,
17.12.1 Company Snapshot
17.12.2 Product Portfolio
17.12.3 Recent Development
17.13 Bio-rad Laboratories, Inc.
17.13.1 Company Snapshot
17.13.2 Revenue Analysis
17.13.3 Product Portfolio
17.13.4 Recent Development
17.14 Cliawaived, Inc.
17.14.1 Company Snapshot
17.14.2 Product Portfolio
17.14.3 Recent Development
17.15 Drugscan
17.15.1 Company Snapshot
17.15.2 Product Portfolio
17.15.3 Recent Development
17.16 Egens Group (Nantong Yishi Biotechnology Co., Ltd.)
17.16.1 Company Snapshot
17.16.2 Product Portfolio
17.16.3 Recent Development
17.17 Hangzhou Alltest Biotech Co.,Ltd
17.17.1 Company Snapshot
17.17.2 Product Portfolio
17.17.3 Recent Development
17.18 Joysbio (Tianjin) Biotechnology Co., Ltd
17.18.1 Company Snapshot
17.18.2 Product Portfolio
17.18.3 Recent Updates
17.19 Lifesign Llc.
17.19.1 Company Snapshot
17.19.2 Product Portfolio
17.19.3 Recent Development
17.20 Merck Kgaa
17.20.1 Company Snapshot
17.20.2 Revenue Analysis
17.20.3 Product Portfolio
17.20.4 Recent Developments
17.21 Mp Biomedicals
17.21.1 Company Snapshot
17.21.2 Product Portfolio
17.21.3 Recent Development
17.22 Premier Biotech, Inc.
17.22.1 Company Snapshot
17.22.2 Product Portfolio
17.22.3 Recent Development
17.23 Sysmex Corporation
17.23.1 Company Snapshot
17.23.2 Revenue Analysis
17.23.3 Product Portfolio
17.23.4 Recent Developments
17.24 Wondfo
17.24.1 Company Snapshot
17.24.2 Product Portfolio
17.24.3 Recent Development
17.25 Xiamen Boson Biotech Co., Ltd.
17.25.1 Company Snapshot
17.25.2 Product Portfolio
17.25.3 Recent Development
18 Questionnaire
19 Related Reports
Table 1 Europe Point-of-care (Poc) Drug Abuse Testing Market, By Drug Type, 2022-2031 (Usd Thousand)
Table 2 Europe Amphetamines In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 3 Europe Opiates In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 4 Europe Cannabinoids In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 5 Europe Cocaine In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 6 Europe Barbiturates In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 7 Europe Benzodiazepines In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 8 Europe Methadone In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 9 Europe Phencyclidine In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 10 Europe Tricyclic Antidepressants In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 11 Europe Others In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 12 Europe Point-of-care (Poc) Drug Abuse Testing Market, By Products, 2022-2031 (Usd Thousand)
Table 13 Europe Devices In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 14 Europe Devices In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Usd Thousand)
Table 15 Europe Devices In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Volume)
Table 16 Europe Analyzer In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Usd Thousand)
Table 17 Europe Immunoassay Analyzer In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Usd Thousand)
Table 18 Europe Breathalyzer In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Usd Thousand)
Table 19 Europe Breathalyzer In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Volume)
Table 20 Europe Devices In Point-of-care (Poc) Drug Abuse Testing Market, By Modality, 2022-2031 (Usd Thousand)
Table 21 Europe Devices In Point-of-care (Poc) Drug Abuse Testing Market, By Mode, 2022-2031 (Usd Thousand)
Table 22 Europe Consumables And Accessories In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 23 Europe Consumables And Accessories In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Usd Thousand)
Table 24 Europe Assay Kits And Reagents In Point-of-care (Poc) Drug Abuse Testing Market, By Test Type, 2022-2031 (Usd Thousand)
Table 25 Europe Assay Kits And Reagents In Point-of-care (Poc) Drug Abuse Testing Market, By Test Type, 2022-2031 (Volume)
Table 26 Europe Assay Kits And Reagents In Point-of-care (Poc) Drug Abuse Testing Market, By Modality, 2022-2031 (Usd Thousand)
Table 27 Europe Point-of-care (Poc) Drug Abuse Testing Market, By Prescription, 2022-2031 (Usd Thousand)
Table 28 Europe Over The Counter Testing In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 29 Europe Prescription-based Testing In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 30 Europe Point-of-care (Poc) Drug Abuse Testing Market, By Sample Type, 2022-2031 (Usd Thousand)
Table 31 Europe Urine In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 32 Europe Saliva In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 33 Europe Blood In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 34 Europe Hair In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 35 Europe Breath In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 36 Europe Others In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 37 Europe Point-of-care (Poc) Drug Abuse Testing Market, By Testing Type, 2022-2031 (Usd Thousand)
Table 38 Europe Random Testing In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 39 Europe Post-incident Testing In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 40 Europe Abstinence Testing In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 41 Europe Point-of-care (Poc) Drug Abuse Testing Market, By Application, 2022-2031 (Usd Thousand)
Table 42 Europe Medical Screening In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 43 Europe Workplace Screening In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 44 Europe Law Enforcement And Criminal Justice In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 45 Europe Pain Management In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 46 Europe Substance Abuse Treatment And Rehabilitation In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 47 Europe Parental Or Home Drug Testing In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 48 Europe Sports And Athletics Testing In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 49 Europe Drug Screening In Schools And Educational Institutions In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 50 Europe Others In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 51 Europe Point-of-care (Poc) Drug Abuse Testing Market, By End User, 2022-2031 (Usd Thousand)
Table 52 Europe Healthcare Facilities In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 53 Europe Healthcare Facilities In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Usd Thousand)
Table 54 Europe Employers In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 55 Europe Government Institutes In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 56 Europe Others In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 57 Europe Point-of-care (Poc) Drug Abuse Testing Market, By Distribution Channel, 2022-2031 (Usd Thousand)
Table 58 Europe Direct Tender In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 59 Europe Retail Sales In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 60 Europe Others In Point-of-care (Poc) Drug Abuse Testing Market, By Region, 2022-2031 (Usd Thousand)
Table 61 Europe Point-of-care (Poc) Drug Abuse Testing Market, By Country, 2022-2031 (Usd Thousand)
Table 62 Europe Point-of-care (Poc) Drug Abuse Testing Market, By Drug Type, 2022-2031 (Usd Thousand)
Table 63 Europe Point-of-care (Poc) Drug Abuse Testing Market, By Products, 2022-2031 (Usd Thousand)
Table 64 Europe Devices In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Usd Thousand)
Table 65 Europe Devices In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Volume)
Table 66 Europe Devices In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Asp)
Table 67 Europe Analyzer In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Usd Thousand)
Table 68 Europe Immunoassay Analyzer In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Usd Thousand)
Table 69 Europe Breathalyzer In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Usd Thousand)
Table 70 Europe Breathalyzer In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Volume)
Table 71 Europe Breathalyzer In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Asp)
Table 72 Europe Devices In Point-of-care (Poc) Drug Abuse Testing Market, By Modality, 2022-2031 (Usd Thousand)
Table 73 Europe Devices In Point-of-care (Poc) Drug Abuse Testing Market, By Mode, 2022-2031 (Usd Thousand)
Table 74 Europe Consumables And Accessories In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Usd Thousand)
Table 75 Europe Assay Kits And Reagents In Point-of-care (Poc) Drug Abuse Testing Market, By Test Type, 2022-2031 (Usd Thousand)
Table 76 Europe Assay Kits And Reagents In Point-of-care (Poc) Drug Abuse Testing Market, By Test Type, 2022-2031 (Volume)
Table 77 Europe Assay Kits And Reagents In Point-of-care (Poc) Drug Abuse Testing Market, By Test Type, 2022-2031 (Asp)
Table 78 Europe Assay Kits And Reagents In Point-of-care (Poc) Drug Abuse Testing Market, By Modality, 2022-2031 (Usd Thousand)
Table 79 Europe Point-of-care (Poc) Drug Abuse Testing Market, By Prescription, 2022-2031 (Usd Thousand)
Table 80 Europe Point-of-care (Poc) Drug Abuse Testing Market, By Sample Type, 2022-2031 (Usd Thousand)
Table 81 Europe Point-of-care (Poc) Drug Abuse Testing Market, By Testing Type, 2022-2031 (Usd Thousand)
Table 82 Europe Point-of-care (Poc) Drug Abuse Testing Market, By Application, 2022-2031 (Usd Thousand)
Table 83 Europe Point-of-care (Poc) Drug Abuse Testing Market, By End User, 2022-2031 (Usd Thousand)
Table 84 Europe Healthcare Facilities In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Usd Thousand)
Table 85 Europe Point-of-care (Poc) Drug Abuse Testing Market, By Distribution Channel, 2022-2031 (Usd Thousand)
Table 86 Germany Point-of-care (Poc) Drug Abuse Testing Market, By Drug Type, 2022-2031 (Usd Thousand)
Table 87 Germany Point-of-care (Poc) Drug Abuse Testing Market, By Products, 2022-2031 (Usd Thousand)
Table 88 Germany Devices In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Usd Thousand)
Table 89 Germany Devices In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Volume)
Table 90 Germany Devices In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Asp)
Table 91 Germany Analyzer In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Usd Thousand)
Table 92 Germany Immunoassay Analyzer In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Usd Thousand)
Table 93 Germany Breathalyzer In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Usd Thousand)
Table 94 Germany Breathalyzer In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Volume)
Table 95 Germany Breathalyzer In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Asp)
Table 96 Germany Devices In Point-of-care (Poc) Drug Abuse Testing Market, By Modality, 2022-2031 (Usd Thousand)
Table 97 Germany Devices In Point-of-care (Poc) Drug Abuse Testing Market, By Mode, 2022-2031 (Usd Thousand)
Table 98 Germany Consumables And Accessories In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Usd Thousand)
Table 99 Germany Assay Kits And Reagents In Point-of-care (Poc) Drug Abuse Testing Market, By Test Type, 2022-2031 (Usd Thousand)
Table 100 Germany Assay Kits And Reagents In Point-of-care (Poc) Drug Abuse Testing Market, By Test Type, 2022-2031 (Volume)
Table 101 Germany Assay Kits And Reagents In Point-of-care (Poc) Drug Abuse Testing Market, By Test Type, 2022-2031 (Asp)
Table 102 Germany Assay Kits And Reagents In Point-of-care (Poc) Drug Abuse Testing Market, By Modality, 2022-2031 (Usd Thousand)
Table 103 Germany Point-of-care (Poc) Drug Abuse Testing Market, By Prescription, 2022-2031 (Usd Thousand)
Table 104 Germany Point-of-care (Poc) Drug Abuse Testing Market, By Sample Type, 2022-2031 (Usd Thousand)
Table 105 Germany Point-of-care (Poc) Drug Abuse Testing Market, By Testing Type, 2022-2031 (Usd Thousand)
Table 106 Germany Point-of-care (Poc) Drug Abuse Testing Market, By Application, 2022-2031 (Usd Thousand)
Table 107 Germany Point-of-care (Poc) Drug Abuse Testing Market, By End User, 2022-2031 (Usd Thousand)
Table 108 Germany Healthcare Facilities In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Usd Thousand)
Table 109 Germany Point-of-care (Poc) Drug Abuse Testing Market, By Distribution Channel, 2022-2031 (Usd Thousand)
Table 110 U.K. Point-of-care (Poc) Drug Abuse Testing Market, By Drug Type, 2022-2031 (Usd Thousand)
Table 111 U.K. Point-of-care (Poc) Drug Abuse Testing Market, By Products, 2022-2031 (Usd Thousand)
Table 112 U.K. Devices In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Usd Thousand)
Table 113 U.K. Devices In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Volume)
Table 114 U.K. Devices In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Asp)
Table 115 U.K. Analyzer In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Usd Thousand)
Table 116 U.K. Immunoassay Analyzer In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Usd Thousand)
Table 117 U.K. Breathalyzer In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Usd Thousand)
Table 118 U.K. Breathalyzer In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Volume)
Table 119 U.K. Breathalyzer In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Asp)
Table 120 U.K. Devices In Point-of-care (Poc) Drug Abuse Testing Market, By Modality, 2022-2031 (Usd Thousand)
Table 121 U.K. Devices In Point-of-care (Poc) Drug Abuse Testing Market, By Mode, 2022-2031 (Usd Thousand)
Table 122 U.K. Consumables And Accessories In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Usd Thousand)
Table 123 U.K. Assay Kits And Reagents In Point-of-care (Poc) Drug Abuse Testing Market, By Test Type, 2022-2031 (Usd Thousand)
Table 124 U.K. Assay Kits And Reagents In Point-of-care (Poc) Drug Abuse Testing Market, By Test Type, 2022-2031 (Volume)
Table 125 U.K. Assay Kits And Reagents In Point-of-care (Poc) Drug Abuse Testing Market, By Test Type, 2022-2031 (Asp)
Table 126 U.K. Assay Kits And Reagents In Point-of-care (Poc) Drug Abuse Testing Market, By Modality, 2022-2031 (Usd Thousand)
Table 127 U.K. Point-of-care (Poc) Drug Abuse Testing Market, By Prescription, 2022-2031 (Usd Thousand)
Table 128 U.K. Point-of-care (Poc) Drug Abuse Testing Market, By Sample Type, 2022-2031 (Usd Thousand)
Table 129 U.K. Point-of-care (Poc) Drug Abuse Testing Market, By Testing Type, 2022-2031 (Usd Thousand)
Table 130 U.K. Point-of-care (Poc) Drug Abuse Testing Market, By Application, 2022-2031 (Usd Thousand)
Table 131 U.K. Point-of-care (Poc) Drug Abuse Testing Market, By End User, 2022-2031 (Usd Thousand)
Table 132 U.K. Healthcare Facilities In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Usd Thousand)
Table 133 U.K. Point-of-care (Poc) Drug Abuse Testing Market, By Distribution Channel, 2022-2031 (Usd Thousand)
Table 134 France Point-of-care (Poc) Drug Abuse Testing Market, By Drug Type, 2022-2031 (Usd Thousand)
Table 135 France Point-of-care (Poc) Drug Abuse Testing Market, By Products, 2022-2031 (Usd Thousand)
Table 136 France Devices In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Usd Thousand)
Table 137 France Devices In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Volume)
Table 138 France Devices In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Asp)
Table 139 France Analyzer In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Usd Thousand)
Table 140 France Immunoassay Analyzer In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Usd Thousand)
Table 141 France Breathalyzer In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Usd Thousand)
Table 142 France Breathalyzer In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Volume)
Table 143 France Breathalyzer In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Asp)
Table 144 France Devices In Point-of-care (Poc) Drug Abuse Testing Market, By Modality, 2022-2031 (Usd Thousand)
Table 145 France Devices In Point-of-care (Poc) Drug Abuse Testing Market, By Mode, 2022-2031 (Usd Thousand)
Table 146 France Consumables And Accessories In Point-of-care (Poc) Drug Abuse Testing Market, By Type, 2022-2031 (Usd Thousand)
Table 147 France Assay Kits And Reagents In Point-of-care (Poc) Drug Abuse Testing Market, By Test Type, 2022-2031 (Usd Thousand)
Table 148 France Assay Kits And Reagents In Point-of-care (Poc) Drug Abuse Testing Market, By Test Type, 2022-2031 (Volume)
Table 149 France Assay Kits And Reagents In Point-of-care (Poc) Drug Abuse Testing Market, By Test Type, 2022-2031 (Asp)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us